83 related articles for article (PubMed ID: 21196076)
21. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
24. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
Ramp U; Caliskan E; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
J Pathol; 2002 Apr; 196(4):430-6. PubMed ID: 11920739
[TBL] [Abstract][Full Text] [Related]
25. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
Hofmockel G; Wittmann A; Dammrich J; Bassukas ID
Anticancer Res; 1996; 16(6B):3807-11. PubMed ID: 9042262
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
27. Glutathione S-transferases as molecular markers of tumour progression and prognosis in renal cell carcinoma.
Searchfield L; Price SA; Betton G; Jasani B; Riccardi D; Griffiths DF
Histopathology; 2011 Jan; 58(2):180-90. PubMed ID: 21255063
[TBL] [Abstract][Full Text] [Related]
28. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
[TBL] [Abstract][Full Text] [Related]
29. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
Shibakita M; Tachibana M; Dhar DK; Kotoh T; Kinugasa S; Kubota H; Masunaga R; Nagasue N
Clin Cancer Res; 1999 Sep; 5(9):2464-9. PubMed ID: 10499620
[TBL] [Abstract][Full Text] [Related]
31. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
Volm M; Koomägi R
Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
[TBL] [Abstract][Full Text] [Related]
32. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
[TBL] [Abstract][Full Text] [Related]
33. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
[TBL] [Abstract][Full Text] [Related]
34. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
[TBL] [Abstract][Full Text] [Related]
35. Expression of Fas/APO-1 in renal cell carcinoma GRC-1 cell line during cell cycles.
Li H; Yu L; Guo Y; Liang Y; Wang D
Chin Med J (Engl); 1999 Nov; 112(11):1008-12. PubMed ID: 11721461
[No Abstract] [Full Text] [Related]
36. The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer.
Duiker EW; van der Zee AG; de Graeff P; Boersma-van Ek W; Hollema H; de Bock GH; de Jong S; de Vries EG
Gynecol Oncol; 2010 Mar; 116(3):549-55. PubMed ID: 19959214
[TBL] [Abstract][Full Text] [Related]
37. Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas.
Tsuzuki H; Sunaga H; Ito T; Narita N; Sugimoto C; Fujieda S
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1071-8. PubMed ID: 16365220
[TBL] [Abstract][Full Text] [Related]
38. Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance.
Lee HJ; Kim DI; Kwak C; Ku JH; Moon KC
Urology; 2008 Sep; 72(3):603-7. PubMed ID: 18384848
[TBL] [Abstract][Full Text] [Related]
39. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.
Tollefson MK; Thompson RH; Sheinin Y; Lohse CM; Cheville JC; Leibovich BC; Kwon ED
Cancer; 2007 Aug; 110(4):783-90. PubMed ID: 17594714
[TBL] [Abstract][Full Text] [Related]
40. CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma.
Gacci M; Serni S; Lapini A; Vittori G; Alessandrini M; Nesi G; Palli D; Carini M
J Urol; 2009 Feb; 181(2):843-8. PubMed ID: 19095263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]